In agreement, Dania et al. 98 have found that IL-1β released by activated inflammasomes in DCs is beneficial to the hyperactivation of DCs and stimulated powerful CTLs responses to strengthen anti-tumor immunity, thereby eradicating tumors in whole organisms. Here, IL1B is linked to neoplasm.